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Abstract The normal physiological contraction of the
urinary bladder, which is required for voiding, is predom-
inantly mediated by muscarinic receptors, primarily the M3
subtype, with the M2 subtype providing a secondary
backup role. Bladder relaxation, which is required for urine
storage, is mediated by β-adrenoceptors, in most species
involving a strong β3-component. An excessive stimulation
of contraction or a reduced relaxation of the detrusor
smooth muscle during the storage phase of the micturition
cycle may contribute to bladder dysfunction known as the
overactive bladder. Therefore, interference with the signal
transduction of these receptors may be a viable approach to
develop drugs for the treatment of overactive bladder. The
prototypical signaling pathway of M3 receptors is activation
of phospholipase C (PLC), and this pathway is also
activated in the bladder. Nevertheless, PLC apparently
contributes only in a very minor way to bladder contraction.
Rather, muscarinic-receptor-mediated bladder contraction
involves voltage-operated Ca
2+ channels and Rho kinase.
The prototypical signaling pathway of β-adrenoceptors is
an activation of adenylyl cyclase with the subsequent
formation of cAMP. Nevertheless, cAMP apparently con-
tributes in a minor way only to β-adrenoceptor-mediated
bladder relaxation. BKCa channels may play a greater role
in β-adrenoceptor-mediated bladder relaxation. We con-
clude that apart from muscarinic receptor antagonists and
β-adrenoceptor agonists, inhibitors of Rho kinase and
activators of BKCa channels may have potential to treat an
overactive bladder.
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Introduction
The urinary bladder stores urine for most of the time and
expels it several times a day. The number of voiding events
is highly species-dependent, i.e., fairly low (less than eight
times per day) in healthy humans, but much higher in some
animals species such as rats and particularly in those which
use voiding as territorial marking behavior such as dogs.
This requires a complex regulation of bladder function,
which is under the control of the nervous system (Andersson
and Arner 2004). Storage of urine requires the bladder body
to distend which is mediated by smooth muscle relaxation
of the detrusor. A key physiological mechanism to induce
detrusor relaxation is β-adrenoceptor (β-AR) stimulation,
which, in most species, involves a strong β3-component,
and in humans, predominantly if not exclusively, occurs via
this receptor (Michel and Vrydag 2006). Concomitantly,
sympathetic stimulation will also stimulate α1-adrenocep-
tors in the bladder neck and urethra to provide bladder
outlet resistance and prevent involuntary leakage of urine
(Michel and Vrydag 2006). When a certain level of filling
of the urinary bladder has been achieved and the central
nervous system has decided that it is a socially acceptable
time to void, efferent signaling switches from sympathetic
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then activates muscarinic receptors in the detrusor to
stimulate smooth muscle contraction and hence voiding
(Abrams et al. 2006; Hegde 2006). This manuscript will
review the signal transduction mechanisms involved in
detrusor contraction by muscarinic receptors and detrusor
relaxation by β-ARs. Other receptors systems, which can
contribute to the regulation of bladder smooth muscle tone
(Andersson 2006; Chetty et al. 2007; Chopra et al. 2005;
Moffatt 2007; Rapp et al. 2005; Ukai et al. 2006), will not
be covered. Moreover, the signal transduction underlying
smooth muscle tone of the bladder neck or urethra will not
be discussed here.
Muscarinic receptor signaling pathways
Although the mammalian bladder expresses more M2 than
M3 receptors, contraction of the normal detrusor appears to
occur largely via M3 muscarinic receptors (Abrams et al.
2006; Hegde 2006). Muscarinic M3 receptors in cell types
other than detrusor smooth muscle cells can couple to a
range of signaling pathways. Among them, stimulation of
phospholipase C (PLC) with the subsequent formation of
inositol trisphosphate (IP3) and diacylglycerol (DAG) to
release Ca
2+ from intracellular stores and to activate a
protein kinase C (PKC), respectively, are considered as
prototypical signaling pathways (Caulfield and Birdsall
1998). However, various other signaling pathways have
been demonstrated to be activated after stimulation of M3
receptors. These include other phospholipases, such as
phospholipase D (PLD; Felder 1995; Mamoon et al. 1999;
Schmidt et al. 1995) and phospholipase A2 (PLA2)/cyclo-
oxygenase (Felder 1995), protein kinases such as phospha-
tidylinositol-3-kinase (PI-3-kinase; Guizzetti and Costa
2001), tyrosine kinases (Inoue et al. 1994), mitogen-
activated protein kinases (MAPK; Larocca and Almazan
1997), particularly those of the extracellular signal-regulated
kinase (ERK) family (Wang et al. 1997) and Rho kinases
(Schmidt et al. 1999), and also a range of ion channels. The
latter group includes ion channels in intracellular organelles
such as ryanodine receptors (Caulfield 1993; Simpson et al.
1996) and those in the plasma membrane including various
types of K
+ channels, voltage-operated Ca
2+ channels, and
store-operated Ca
2+ channels (Caulfield 1993). Most of
these mechanisms have also been investigated for detrusor
smooth muscle.
Phospholipase C
Activation of PLC is the prototypical signaling pathway of
M3 receptors (Caulfield and Birdsall 1998). It is believed to
primarily occur via the α-subunits of Gq/11 G-proteins.
Apart from the phosphatidylinositol-PLC (PI-PLC), which
generates IP3, this can also involve phosphatidylcholine-
PLC (PC-PLC), both of which will lead to DAG formation
(Caulfield and Birdsall 1998; Ehlert et al. 1997). Data in
gastrointestinal smooth muscle indicate that PI-PLC may be
involved in regulation of the phasic contraction, whereas
PC-PLC may contribute to sustaining smooth muscle tone
(Makhlouf and Murthy 1997).
Previous studies demonstrated that muscarinic receptor
stimulation bycarbachol inrat orguineapigbladder enhances
the formation of IP (Kories et al. 2003; Marsh et al. 1996;
Nelson et al. 2004; Schneider et al. 2004b). Using the
subtype-selective antagonist, darifenacin, the carbachol-
stimulated IP formation in the urinary bladder was demon-
strated to indeed occur predominantly if not exclusively via
M3 receptors (Kories et al. 2003;N e l s o ne ta l .2004).
An involvement of PLC in bladder tone has been
assessed using several inhibitors: U 73,122 and ET-18-
OCH3 were used as PI-PLC inhibitors, D609 as a PC-PLC
inhibitor, and neomycin as a non-specific PLC inhibitor.
Alternatively, IP3 receptor inhibitors such as 2-amino-
ethoxyphenyl borate (2-APB) or heparin have also been
used. The effects of 2-APB on bladder function are not easy
to understand because this compound was reported to
increase the frequency of spontaneous action potentials but
nevertheless to reduce contraction amplitudes in the
absence of autonomic stimulation in guinea pig detrusor
smooth muscle cells (Imai et al. 2002). While studies in
guinea pig bladder did not detect inhibitory effects of 2-
APB, similar experiments in rat bladder reported this
compound to inhibit carbachol-induced calcium sensitiza-
tion (Durlu-Kandilci and Brading 2006). Similarly, intra-
cellular heparin administration was reported to inhibit
acetylcholine-induced contraction of feline detrusor cells
(An et al. 2002). The latter study in cats has also suggested
that PLC activation may be necessary for muscarinic
agonist-induced bladder contraction using the PLC inhibitor
neomycin (An et al. 2002). Studies in rats using ET-18-
OCH3 have also proposed an involvement of PI-PLC in rat
bladder contraction, although this was not confirmed within
the same study when neomycin was used as the inhibitor
(Braverman et al. 2006b). In contrast, other groups of
investigators using different experimental protocols and the
PLC inhibitor U 73,122 have reached somewhat different
conclusions, as this compound did not affect carbachol-
induced contraction in rat (Schneider et al. 2004b), mouse
(Wegener et al. 2004), or human bladder (Schneider et al.
2004a) in concentrations where it fully suppressed IP
formation in rat bladder slices (Schneider et al. 2004b).
As the contradictory conclusions in rats were based upon
different inhibitors (ET-18-OCH3 and U 73,122) and on
different experimental protocols (single vs multiple con-
centration–response curves per muscle strip), these inves-
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which each lab used its own protocol to test the inhibitors
previously used by the other laboratory (Frazier et al.
2007). In that study, neither of the PI-PLC inhibitors tested
[U 73,122 (Fig. 1) and ET-18-OCH3] exerted a significant
inhibition of the carbachol-induced bladder contraction. In
confirmation of the earlier study (Braverman et al. 2006b),
the PC-PLD inhibitor D609 was quite effective in high
concentrations, but at this concentration, it also attenuated
contraction in response to the receptor-independent stimu-
lus KCl, indicating that the D609 response was not specific
to the muscarinic receptor activation. These crossover
experiments indicated that M3-receptor-mediated PLC
activation in the rat bladder is not a major contributor to
detrusor contraction.
Phospholipase D
PLD is located in the plasma membrane and can catalyze
the hydrolysis of phophatidylcholine to form phosphatidic
acid (PA). Hydrolysis of PA by the enzyme PA phosphohy-
drolase forms DAG. DAG can be converted back into PA
by DAG kinase. Although DAG and PA are interchange-
able, they do not share the same signaling mechanisms to
exert their biological effects. Because DAG can also be
generated upon stimulation of PI-PLC and PC-PLC (see
above), it is difficult to identify the enzyme responsible for
DAG formation. A potential role of DAG will be discussed
further below in the context of a role for PKC.
An involvement of PLD in biological responses can be
assessed using the inhibitor butan-1-ol and its isomer butan-
2-ol, which does not inhibit PLD (Banno et al. 2001).
Another PLD inhibitor, which has been used in bladder
studies, is para-chloromercuribenzoic acid (An et al. 2002;
Yang et al. 2000). In rat bladder slices, carbachol caused
only a little, if any, PLD activation compared to the positive
control phorbol myristate acetate (Schneider et al. 2004b).
Accordingly,inratandhuman urinarybladder,butan-1-ol,as
compared to its inactive control, caused only little inhibition,
which was limited to its highest concentration (Schneider et
al. 2004a). Similarly, para-chloromercuribenzoic acid did
not inhibit contractile response to acetylcholine in feline
detrusor (An et al. 2002; Yang et al. 2000). Taken together,
these data suggest that PLD only plays a minor, if any, role
in muscarinic receptor agonist-induced contraction of the
urinary bladder.
Phospholipase A2/cyclooxygenase
PLA2 specifically catalyzes the hydrolysis of the sn-2 fatty
acyl bond of phospholipids to generate free fatty acid and
lysophospholipids, comprising arachidonic acid (AA)
which can be further metabolized to prostaglandins by
cyclooxygenase (Felder 1995). There are two main families
of PLA2 containing several members with common
enzymatic activity. One family of PLA2 is the small
molecular weight secretory PLA2 which consists of mainly
calcium-dependent enzymes. The other family consists of
both calcium-dependent and calcium-independent cytosolic
PLA2 (cPLA2) isoforms and can be inhibited by 1,1,1-
trifluoromethyl-6,9,12,15-eicosatetraen-2-one. Studies into
a role for PLA2 in muscarinic-receptor-induced bladder
contraction have mainly focussed on cPLA2. Moreover,
several cyclooxygenase products can also generate detrusor
smooth muscle contraction (Andersson 2000). At least in
rat bladder, protease-activated receptor-2-induced contrac-
tion is partly mediated by activation of cyclooxygenase
(Nakahara et al. 2004).
A study in rat bladder using 1,1,1-trifluoromethyl-
6,9,12,15-eicosatetraen-2-one indicated only a very minor,
if any, role for PLA2 in carbachol-induced contraction
(Schneider et al. 2004b). Moreover, in the same study,
inhibition of cyclooxygenase by indomethacin at a concen-
tration inhibiting protease-activated receptor-2-mediated
contraction (Nakahara et al. 2004) did not inhibit the
carbachol response. Similar findings were obtained in feline
bladder (An et al. 2002). Hence, the available data suggest
that neither of PLA2 nor cyclooxygenase plays a major role
in the muscarinic-receptor-mediated bladder contraction,
although this may be different for other contractile stimuli
such as protease-activated receptor-2-induced contraction,
which is partly mediated by activation of cyclooxygenase
(Nakahara et al. 2004) or bradykinin (Kubota et al. 2003).
Protein kinase C
PKC is physiologically activated by DAG, and this can
occur subsequent to stimulation of PI-PLC, PC-PLC or
PLD (see above) and, in some types of smooth muscle, may
contribute to the sustained phase of contraction (Aburto et
Fig. 1 Effect of U 73,122 (10 μM) alone and in combination with
darifenacin (30 nM) on carbachol-induced rat bladder contraction.
Taken from (Frazier et al. 2007)
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assessed using PKC inhibitors such as chelerythrine,
calphostin C, Gö 6850, and GF 109203X, but most of
these inhibitors can have ancillary properties which
complicate interpretation of the data. A role for PKC can
also be studied using activators such as β-phorbol-12,13-
dibutyrate. While the later activates PKC upon short-term
exposure, longer exposure can reduce cellular PKC activity.
Finally, it should be considered that some muscarinic
receptor antagonists such as propiverine and its metabolites
also can have PKC inhibitory effects in the bladder (Moritz
et al. 2005); however, apart from its muscarinic receptor
antagonism, propiverine and some of its metabolites also
have calcium channel blocking activity, which further
complicates interpretation of data obtained with this
compound (Michel and Hegde 2006).
The PKC activator β-phorbol-12,13-dibutyrate augments
bladder contractility by electrical field stimulation in mouse
and rat (Liu and Lin-Shiau 2000; Weng et al. 2005). While
a PKCinhibitormay attenuate muscarinic-receptor-mediated
calcium sensitization in the rat or guinea pig bladder (Durlu-
Kandilci and Brading 2006), such drugs did not inhibit peak
contractile responses to muscarinic agonists in rat (Durlu-
Kandilci and Brading 2006; Fleichman et al. 2004), feline
(An et al. 2002), or human bladder (Schneider et al. 2004a).
Thus, the overall role for PKC in muscarinic-receptor-
mediated bladder contraction appears small, which is in line
with the negative data regarding an involvement of PI-PLC,
PC-PLC, and PLD.
Tyrosine kinases
Tyrosine kinase signaling can be involved in Ca
2+
sensitization in smooth muscle, and this may involve the
activation of RhoA and Rho kinase (ROCK; Somlyo and
Somlyo 2003). The role of tyrosine kinases in modulating
vascular, visceral, and airway smooth muscle contraction
has been documented (Chopra et al. 1997; Dessy et al.
1998; Di Salvo et al. 1994; Grasa et al. 2006; Jin et al.
1996; Jinsi et al. 1996; Steusloff et al. 1995; Tolloczko et
al. 2000), specifically for the src family of tyrosine kinases
(Roberts 2001; Tolloczko et al. 2002). Tyrosine kinases
have also been reported to control Ca
2+ entry and
intracellular Ca
2+ concentration in vascular smooth muscle
(Carter and Kanagy 2002; Lagaud et al. 1999; Toma et al.
1995; Wijetunge et al. 2000).
Tools to asses an involvement of tyrosine kinase include
genistein and its negative control daidzein, the src-specific
inhibitor PP1, PP2, and its negative control PP3, and the
c-kit tyrosine kinase inhibitor (Glivec®). In the guinea pig
detrusor smooth muscle, which expressed c-kit positive cells,
the c-kit tyrosine kinase inhibitor concentration-dependently
suppressed the spontaneous contraction whereas carbachol-
induced contraction was only attenuated by a high concentra-
tion of the c-kit inhibitor (Kubota et al. 2004). Similarly,
neither genistein nor PP2 inhibited the carbachol-induced
contraction of rat bladder (Fleichman et al. 2004). Thus,
tyrosine kinases apparently do not contribute to muscarinic
receptor agonist-induced bladder contraction in a major way.
Mitogen-activated kinase
Studies on a role of the ERK family of MAPK in vascular
smooth muscle contraction have yielded conflicting results
with positive (Dessy et al. 1998; Fetscher et al. 2001;
Roberts 2001;X i a oa n dZ h a n g2002) and negative
(Altmann et al. 2003; Janssen et al. 2001; Watts et al.
1998) data having been reported. PD 98,059 and U 126 are
inhibitors of ERK activation, and U 124 is a negative
control for the latter. ERK signaling has been suggested to
be involved in the rat urinary bladder contraction during
inflammation induced by uropathogenic Escherichia coli,
but not in healthy bladder contraction (Weng et al. 2006).
Accordingly, inhibition of ERK activation by PD 98,059 or
U 126 did not attenuate the carbachol response in the
normal rat bladder (Fleichman et al. 2004), indicating that
ERK activation is not required for the muscarinic-receptor-
induced bladder contraction under physiological condition.
Phosphatidylinositide 3-kinase
PI-3-Ksareenzymesthatspecificallycatalyzephosphorylation
of the 3-position in the inositol ring of the phosphoinositides
(Rameh and Cantley 1999). They are ubiquitously expressed,
and multiple isoforms exist (Northcott et al. 2004; Rameh and
Cantley 1999). Activation of PI-3-kinases has been associated
with smooth muscle contraction in colonic (Ibitayo et al.
1998) and some preparations of vascular smooth muscle cells
via Rho kinase-dependent inhibition of MLCP (Wang et al.
2006; Yoshioka et al. 2007), but they may not be involved in
smooth muscle tone of other preparations (Altmann et al.
2003). Wortmannin and LY294002 are commonly used PI-
3-kinase inhibitors, and an inactive analogue of LY294002
exists. A single study in rat bladder using wortmannin,
LY294002, and the inactive analogue of the latter did not
support a role for PI-3-kinase in carbachol-induced contrac-
tion (Fleichman et al. 2004).
Rho kinase
ROCK are serine/threonine kinases of ∼160 kDa and play a
role in various cellular functions (Riento and Ridley 2003;
Somlyo and Somlyo 2003). Two isoforms designated as
ROCK I (also known as ROKb or p160ROCK) and ROCK
II (ROKa or Rho kinase) exist. These isoforms and their
physiological activator RhoA are expressed in many
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protein level (Chang et al. 2006; Takahashi et al. 2004;
Wibberley et al. 2003). ROCK activation can enhance
smooth muscle contraction by multiple mechanisms (Riento
and Ridley 2003; Somlyo and Somlyo 2003).
Y-27,632, fasudil, and HA-1077 are ROCK inhibitors
which are commonly used to assess the involvement of this
kinase in biological responses. In the urinary bladder of
humans (Fig. 2) and other mammals, Y-27,632, fasudil, and
HA-1077 inhibit both phasic and sustained contraction
induced by several stimuli including muscarinic receptor
agonists (Braverman et al. 2006a; Fleichman et al. 2004;
Jezior et al. 2001; Schneider et al. 2004a,b; Speich et al.
2005; Takahashi et al. 2004; Wibberley et al. 2003).
Whereas all available studies indicate that ROCK inhibitors
reduced potency of muscarinic receptor agonist carbachol
in the bladder, results regarding the carbachol efficacy are
conflicting (Braverman et al. 2006b; Fleichman et al. 2004;
Schneider et al. 2004a, 2005; Takahashi et al. 2004). Based
upon a reduction of the potency of M3-selective antagonist
darifenacin in the presence of Y-27,632, it has been
proposed that ROCK may have a specific role in the M2
receptor contribution to bladder tone (Braverman et al.
2006b). As the overall role of M2 receptors in bladder tone
requires further clarification (Abrams et al. 2006; Hegde
2006), this proposal is awaiting confirmation by other
investigators. In contrast to the consistently reported role of
ROCK in muscarinic-receptor-mediated bladder contraction
in vitro, ROCK inhibitors were reported not to affect
physiological bladder contraction in vivo in healthy
animals, but only under pathophysiological conditions
(Rajasekaran et al. 2005). A possible role of ROCK in
bladder dysfunction and its treatment has recently been
reviewed (Peters et al. 2006).
Ca
2+ channels
Similar to all other types of smooth muscle, bladder
contraction requires elevation of intracellular Ca
2+ concen-
trations. While several studies have demonstrated that
removal of extracellular Ca
2+ will impair muscarinic-
receptor-mediated bladder contraction (Jezior et al. 2001;
Visser and van Mastrigt 2000), the relative roles of influx
from the extracellular space and of mobilization from
intracellular stores remain a subject of discussion and
possibly are species-dependent (Wuest et al. 2007). At
least four types of Ca
2+ channels can be involved in bladder
smooth muscle contraction, including voltage-operated
channels, store-operated channels, IP3-receptors, and rya-
nodine receptors. Voltage-operated and store-operated Ca
2+
channels are abundant in the plasma membrane and
contribute to the influx of Ca
2+ from extracellular space,
whereas Ca
2+ release from intracellular stores involves
activation of IP3 and ryanodine receptors in the membranes
of the sarcoplasmic reticulum.
The group of voltage-operated Ca
2+ channels contains
several types, among which, the L-type appears most
relevant and has been most frequently studied with regard
to the bladder. L-type Ca
2+ channels can be inhibited by
drugs such as nifedipine or diltiazem. Moreover, knockout
mice have been generated, which lack a crucial subunit of
L-type Ca
2+ channels (Wegener et al. 2004). Various
investigators have shown that L-type Ca
2+ channel inhib-
itors reduce muscarinic-receptor-mediated detrusor contrac-
tion in rat (Schneider et al. 2004b), mouse (Wuest et al.
2007), rabbit (Zderic et al. 1994), pig (Buckner et al. 2002;
Uchida et al. 1994; Wuest et al. 2007), and human (Fig. 3;
Masters et al. 1999; Schneider et al. 2004a; Wuest et al.
2007). Interestingly, inhibition of bladder contraction was
observed at inhibitor concentrations which are lower than
those typically required to inhibit the contraction of
vascular smooth muscle. Accordingly, knockout mice for
the Cav1.2 L-type Ca
2+ channel exhibited markedly
reduced detrusor contraction in response to muscarinic
Fig. 2 Effects of the Rho kinase inhibitor Y 27,632 and its vehicle on
carbachol-induced contraction. The upper panel shows carbachol
concentration-response curves in the absence and presence of various
Y 27,632 concentrations. The lower two panels show alterations of
pEC50 and Emax relative to matched time controls. *p<0.05, **p<0.01
vs matching time controls in the presence of vehicle in a two-way
analysis of variance followed by Dunnet post-tests. Taken from
(Schneider et al. 2004a)
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(Wegener et al. 2004). While it has been proposed that Q-
type voltage-operated Ca
2+ channels may also contribute to
bladder tone under some circumstances, N- and T-type Ca
2+
channels apparently are not involved (Frew and Lundy
1995). Similarly, non-selective cation channels, Ca
2+-
activated Cl
− channels, and Na
+/Ca
2+ exchanger do not
play major role in Ca
2+ influx in the bladder (Ganitkevich
and Isenberg 1992; Nakayama and Brading 1993).
While the relative role of L-type Ca
2+ channels in the
muscarinic-receptor-mediated detrusor contraction may
differ between species (Wuest et al. 2007), the above data
clearly demonstrate their overall importance. However, this
does not exclude the possibility that their role may be
indirectly, e.g., related to the filling of intracellular stores
acted upon by other signaling pathways. Moreover, a
number of relevant questions remain to be answered.
Firstly, the specific mechanism of how muscarinic receptor
activation couples to L-type Ca
2+ channels remains to be
elucidated. In this regard, it has been proposed that at least
in guinea pigs, the Ca
2+ needed for contraction enters the
cell through voltage-dependent Ca
2+ channels and is then
pumped into an intracellular store from where it is released
by muscarinic agonists (Rivera and Brading 2006). Other
work in guinea pigs also supports a role for L-type Ca
2+
channels in maintaining Ca
2+ entry and refilling intracellu-
lar stores in detrusor smooth muscle (Wu et al. 2002).
Secondly, some electrophysiological studies across multiple
species have reported that muscarinic agonists may inhibit
the current through L-type Ca
2+ channels (Kajioka et al.
2002; Yoshino and Yabu 1995). Those authors argued that
this may involve Ca
2+-mediated inactivation of Ca
2+
channels triggered by the release of Ca
2+ from IP3 and
thapsigargin-sensitive internal stores or by a G-protein-
mediated mechanism. The reason for the discrepancy
between these electrophysiological studies and the contrac-
tility data based upon pharmacological channel inhibitors
and knockout mice remains to be elucidated. Thirdly, some
clinically used muscarinic receptor antagonists including
oxybutynin (Kachur et al. 1988) and propiverine (Wuest et
al. 2006) and/or their metabolites (Michel and Hegde 2006)
also have direct inhibitory effects on L-type Ca
2+ channels.
How much this may contribute to their clinical effects on
the bladder remains to be determined. Finally, inhibitors of
L-type Ca
2+ channels are frequently used in the treatment
of cardiovascular disease, but during their use, no major
adverse events on bladder function have surfaced. The
reasons for a major role of such channels in bladder
contractility vs a lack of adverse effects of their inhibitors
on the bladder may relate to pharmacokinetic properties of
the clinically used drugs, which may not reach sufficiently
high concentrations in bladder tissue.
Calcium can also enter the cell from the extracellular
space via store-operated Ca
2+ channels which are sensitive
to the inhibitor SK&F 96,365. However, SK&F 96,365 was
reported to exert only minor, if any, inhibition of carbachol-
induced rat bladder contraction (Schneider et al. 2004b).
Therefore, it is difficult to judge other findings reporting
that suppression of IP3 release may impair store-operated
Ca
2+ channel function (Bootman et al. 2002).
With regard to channels mediating calcium mobilization
from intracellular stores, a possible role of the IP3 receptor
as a Ca
2+ channel involved in bladder contraction has been
discussed in the PLC section. Another type of channel
possibly involved in mobilization of calcium from intracel-
lular stores is the ryanodine receptor, which can be
inhibited by ryanodine and is expressed in the human
urinary bladder (Chambers et al. 1999). Ryanodine has
been reported to inhibit bladder contraction in rabbits
(Zderic et al. 1994), guinea pig (Buckner et al. 2002), and
human bladder (Visser and van Mastrigt 2000), but other
investigators did not confirm such inhibition in mouse, pig,
or human bladder (Wuest et al. 2007). Ryanodine receptors
have also been implied in the muscarinic stimulation of
large transient inward and small oscillating inward currents
in porcine bladder (Kajioka et al. 2005), but the relationship
Fig. 3 Effects of the Ca
2+ channel inhibitor nifedipine and its vehicle
on carbachol-induced contraction. The upper panel shows carbachol
concentration-response curves in the absence and presence of various
nifedipine concentrations. The lower two panels show alterations of
pEC50 and Emax relative to matched time controls. *p<0.05, ***p<
0.001 vs matching time controls in the presence of vehicle in a two-
way analysis of variance followed by Dunnet post-tests. Taken from
(Schneider et al. 2004a)
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remains to be defined.
β-Adrenoceptor relaxation signaling pathways
Noradrenaline released from the hypogastric nerves acti-
vates β-AR and induces detrusor smooth muscle relaxation.
All three cloned β-AR subtypes are present in the urinary
bladder of rat and humans at the mRNA level, and at least
in humans, the β3-AR is by far the most abundantly
expressed subtype (Fujimura et al. 1999; Matsubara et al.
2002; Seguchi et al. 1998). Studies at the protein level are
difficult to interpret because none of the available radio-
ligands is suited to detect β3-AR (Baker 2005; Hoffmann et
al. 2004; Niclauss et al. 2006). Functionally, it appears that
detrusor relaxation involves a strong β3-AR component in
most species and may be the predominant, if not sole,
mediator of bladder relaxation in humans (Michel and
Vrydag 2006). Additional contributions by other β-AR
subtypes are less well defined and may differ between
species (Michel and Vrydag 2006). Most studies on signal
transduction processes underlying β-AR-mediated bladder
relaxation have not specifically studied receptor subtypes,
and hence, it remains possible that some of the effects
described below actually represent a mixture of effects
mediated by multiple subtypes.
Cyclic AMP formation
The prototypical signaling pathway of β-AR is activation of
adenylyl cyclase to elevate intracellular cAMP concentrations
(Bylund et al. 1994). Sequentially, cAMP activates protein
kinase A (PKA) or alternative effector molecules such as
epac (Schmidt et al. 2007) to mediate smooth muscle
relaxation. Hence, β-AR agonists such as isoprenaline can
elevate cAMP formation in rat bladder smooth muscle cells
(Derweesh et al. 2000;M ae ta l .2002;U c h i d ae ta l .2005).
The functional role of adenylyl cyclase can be tested by
inhibitors such as SQ 22,536 or Rp-cAMPs, whereas that of
PKA can be assessed by inhibitors including H7 and H89.
To test the role of cAMP formation and PKA in bladder
relaxation, three studies have recently been reported from
rat bladder. In one study using the β2-agonist clenbuterol
against field stimulation-induced tone, a PKA inhibitor was
reported to block relaxation while not affecting the field
stimulation-induced contraction (Hudman et al. 2000). Two
other studies investigated used isoprenaline as the agonist
(one additionally included a β3-selective agonist) against
the effects of isoprenaline on both passive tension and KCl-
induced tone (Fig. 4; Frazier et al. 2005; Uchida et al.
2005). Both studies have used adenylyl cyclase inhibitors
such as SQ 22,536 and Rp-cAMPs and also PKA inhibitors
such as H7 and H89. While their quantitative findings differ
slightly, they both show that cAMP formation does not
contribute to relaxation against KCl-induced tone. While
some contribution exists for relaxation against passive
tension, even under those conditions, it may account for
only a minor part of the response. One of the studies
additionally demonstrates that a guanylyl cyclase also is not
involved to a major extent (Frazier et al. 2005). These
findings indicate that the cAMP/PKA pathway may
contribute to bladder relaxation by a β2-AR, but less, if at
all, to that induced by a β3-selective or a non-selective
Fig. 4 Effect of the adenylyl
cyclase inhibitor SQ 22,536
(1 μM) and the protein kinase A
inhibitor H7 (10 μM) on iso-
proterenol-induced relaxation of
rat urinary bladder. Taken from
(Frazier et al. 2005)
Naunyn-Schmiedeberg’s Arch Pharmacol (2008) 377:449–462 455agonist. The latter findings are in line with recent data from
various other types of smooth muscle which have indicated
that various types of K
+ channels may be more important in
β-AR-mediated relaxation than cAMP (Ferro 2006).
K
+ channels
Numerous types of K
+ channels exist, which are not only
activated under distinct conditions but also mediate different
physiological functions (Brading 1992). Channels which
have been investigated in the bladder include voltage-gated
(Kv) channels (Davies et al. 2002; Thorneloe and Nelson
2003), small conductance (SK) channels (Heppner et al.
2003; Herrera et al. 2000; Herrera and Nelson 2002), ATP-
sensitive (KATP) channels (Bonev and Nelson 1993; Buckner
et al. 2000; Gopalakrishnan et al. 1999), and large
conductance Ca
2+-activated K
+ channels (BKCa) channels
(Klockner and Isenberg 1985; Markwardt and Isenberg
1992; Petkov et al. 2001;S u a r e z - K u r t ze ta l .1991; Trivedi
et al. 1995;Z o g r a f o se ta l .1992). Many of these channels
can be activated by β-AR stimulation, leading to an efflux of
potassium and, hence, a hyperpolarization and reduced tone
of the smooth muscle cells (Ferro 2006). The available data
indicate that KATP and BKCa channels are the two types of
K
+ channels which provide the greatest contributions to
detrusor smooth muscle tone.
Kv channels are expressed in human urinary bladder
(Davies et al. 2002) and have been reported to be
functionally important in regulating detrusor tone both in
mouse (Thorneloe and Nelson 2003) and human bladder
(Chen et al. 2004; Davies et al. 2002). However, no data on
their possible involvement in β-AR-mediated bladder
relaxation has been reported.
KATP channels are expressed in rat (Ha et al. 1993),
guinea pig (Gopalakrishnan et al. 1999), pig and human
detrusor (Buckner et al. 2000). Their functional role can be
assessed by activators such as pinacidil, cromakalim, or
rimakalim or by inhibitors such as glibenclamide. Their
overall role in the regulation of bladder smooth muscle tone
is documented by numerous in vitro and in vivo studies
demonstrating that KATP channel openers can relax bladder
smooth muscle. Such data were obtained for several
representatives of this drug class including pinacidil
(Edwards et al. 1991; Malmgren et al. 1990; Vijayakumar
et al. 2007), cromakalim (de Moura et al. 1993; Foster et al.
1989a,b; Fujii et al. 1990;M a l m g r e ne ta l .1990;
Vijayakumar et al. 2007), lemakalim (Bonev and Nelson
1993), rimakalim (Wuest et al. 2005), ZD097 (Aishima et
al. 2006), ZD 6169, and WAY-133537 (Gopalakrishnan et
al. 2002). Such functional data were reported from various
species including rat (Edwards et al. 1991; Hudman et al.
2000), mouse (de Moura et al. 1993), guinea pig (Bonev
and Nelson 1993; Foster et al. 1989a; Fujii et al. 1990;
Gopalakrishnan et al. 1999), pig (de Moura et al. 1993;
Foster et al. 1989b; Uchida et al. 1994), goat (Vijayakumar
et al. 2007), and humans (Aishima et al. 2006; de Moura et
al. 1993; Foster et al. 1989b; Gopalakrishnan et al. 2002).
This broad spectrum of species shows that the role of KATP
channels for bladder smooth muscle tone stretches across
mammalian species. Moreover, KATP channel openers reduce
both spontaneous and agonist-induced contraction of the
detrusor, independent of the contractile stimulus being used
(Buckner et al. 2000;M a l m g r e ne ta l .1990). Their effects
also are independent of the presence of a functional
urothelium, with the possible exception of pigs (de Moura
et al. 1993), underscoring their primary direct effects on the
smooth muscle cells. However, a key problem with the use
of KATP channel openers is that they also work on vascular
smooth muscle cells and, therefore, lower blood pressure in
vivo (Foster et al. 1989a,b). Therefore, it is not surprising
that a clinical study using a KATP channel opener in OAB
patients at a non-hypotensive dose failed to detect symptom
improvement (Chapple et al. 2006)
While the above data clearly demonstrate the importance
of KATP channels in the regulation of bladder tone, they do
not allow direct conclusions regarding their role in β-AR-
mediated bladder relaxation. This can be assessed by testing
the effects of KATP channel inhibitors such as glibenclamide
against β-AR stimulation (Frazier et al. 2005; Hudman et
al. 2000). Glibenclamide abolished relaxation of field
stimulation-induced contraction by the β2-AR agonist
clenbuterol in rat bladder (Hudman et al. 2000). On the
other hand, glibenclamide failed to attenuate the relaxant
effect of isoprenaline in rat bladder against passive or KCl-
induced tension (Frazier et al. 2005). These data highlight
the possibility that different β-AR subtypes in the bladder
may utilize distinct signaling pathways to elicit smooth
muscle relaxation.
SK channels are expressed in the urinary bladder (Chen
et al. 2004), and their role in bladder function has been
reviewed previously (Heppner et al. 2003). SK channels are
Ca
2+-sensitive and can be activated by the influx of Ca
2+
via voltage-operated Ca
2+ channels (Herrera and Nelson
2002). They can influence the function of ryanodine
receptors in the detrusor (Herrera et al. 2000). In guinea
pigs, SK channels play a role as a negative feedback
element to reduce the amplitude and duration of detrusor
contraction (Herrera et al. 2000). In vivo studies in
genetically modified mice either overexpressing the SK3
isoform in the bladder or having an inducible knockdown
of this channel demonstrated a greater bladder capacity in
the overexpression as compared to the WT mice and those
with reduced SK3 expression. Moreover, the mice with
suppressed SK3 expression exhibited marked increases of
non-voiding contraction, suggesting a role of these channels
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However, an involvement of these channels in the β-AR-
mediated bladder relaxation has not been reported.
Ar o l ef o rB K Ca channels can be assessed pharmacolog-
ically by inhibitors such as charybdotoxin or iberiotoxin.
Functional evidence, based upon pharmacological modula-
tion as well as genetically modified animals, demonstrates a
role for BKCa channels in regulating detrusor tone in rats
(Christ et al. 2001; Malysz et al. 2004), mice (Meredith et al.
2004; Petkov et al. 2001), guinea pigs (Grant and Zuzack
1991; Klockner and Isenberg 1985; Markwardt and Isenberg
1992;S u a r e z - K u r t ze ta l .1991; Woods et al. 2001;Z o g r a f o s
et al. 1992), pigs and humans (Trivedi et al. 1995). They
have been reported to mediate repolarizing of the membrane
potential and maintaining the resting potential (Heppner et
al. 1997; Karicheti and Christ 2001). Moreover, at least in
guinea pigs, they have been proposed to provide a negative
feedback element to reduce the amplitude and duration of
detrusor contraction (Herrera et al. 2000). In mice, this role
is regulated by the smooth-muscle-specific pore-forming β1-
subunit (Petkov et al. 2001). Similar to SK channels, BKCa
channels are Ca
2+-sensitive and can be activated by the
influx of Ca
2+ via voltage-operated Ca
2+ channels (Herrera
and Nelson 2002). In contrast to SK channels, BKCa
channels are also activated by the Ca
2+-induced Ca
2+ spark
by ryanodine receptors, and such activation has been
reported in the detrusor of guinea pigs (Herrera et al. 2001;
Herrera and Nelson 2002; Ohi et al. 2001) and humans
(Chambers et al. 1999). Accordingly, it has been suggested
that BKCa channels and ryanodine receptors are co-localized
at the sub-plasmalemma and in sarcoplasmic reticulum
fragments to generate Ca
2+ sparks to activate spontaneous
transient outward currents (Ohi et al. 2001). The strength of
coupling of Ca
2+ sparks to BKCa channels is regulated by
membrane potential and stimuli which modulates Ca
2+
sensitivity (Herrera et al. 2001). Thus, BKCa are important
in the regulation of bladder tone, and activators of BKCa
channels have been synthesized as possible drugs for the
treatment of overactive bladder (Hewawasam et al. 2002;
Sheldon et al. 1997; Turner et al. 2003).
In guinea pig bladder, stimulation of β-AR activates
BKCa channels via Ca
2+-sensitive mechanisms by means of
increase of Ca
2+ influx and Ca
2+ sparks (Petkov and Nelson
2005). Some investigators have demonstrated the involve-
ment of BKCa channels in β-AR-mediated bladder relaxa-
tion using BKCa channel inhibitors such as iberiotoxin and
charybdotoxin in rats (Frazier et al. 2005; Uchida et al.
2005) and guinea pigs (Kobayashi et al. 2000; Petkov and
Nelson 2005). Studies in rats have demonstrated that the
role of BKCa channels in β-AR-mediated relaxation may
depend on the experimental conditions, i.e., being consid-
erable in the presence of KCl-induced tone but absent in the
presence of passive tension only (Fig. 5; Frazier et al. 2005;
Uchida et al. 2005). While a study in guinea pigs has
reported that β-AR relaxation is mediated by facilitation of
BKCa channels following the activation of cAMP/PKA
pathways (Kobayashi et al. 2000), studies in rats do not
support the idea of a concomitant involvement of BKCa
channels and the cAMP/PKA pathway (Frazier et al. 2005;
Uchida et al. 2005).
Fig. 5 Effects of the BKCa
channel inhibitors iberiotoxin
(30 nM) and charybdotoxin
(30 nM) on isoproterenol-
induced relaxation of rat
urinary bladder. Taken from
(Frazier et al. 2005)
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Muscarinic receptors, specifically their M3 subtype, are an
important physiological mediator of bladder contraction.
Although an activation of PLC is the prototypical signaling
pathway of these receptors and this pathway is also
activated in the bladder, PLC apparently only contributes
to bladder contraction in a very minor way. Rather,
muscarinic-receptor-mediated bladder contraction involves
voltage-operated Ca
2+ channels and ROCK. While currently
available inhibitors of voltage-operated Ca
2+ channels have
little effect on bladder function in vivo in patients, ROCK
inhibitors may have potential as drugs for the treatment of
an overactive bladder. β-AR, specifically β3-AR, are
important physiological mediators of bladder relaxation,
and selective β3-AR agonists are currently in clinical
development for the treatment of an overactive bladder.
Although the prototypical signaling pathway of β-AR is an
activation of adenylyl cyclase with the subsequent formation
of cAMP, cAMP apparently contributes to β-AR-mediated
bladder relaxation only in a minor way. BKCa channels may
play a greater role in β-AR-mediated bladder relaxation, and
activators of these channels are also under investigation to
treat an overactive bladder.
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